Technology - Pharmaceutical Executive


Information Technology in pharma: enterprise management, business intelligence, clinical trials management, sales force automation, closed-loop marketing, and more.

Regeneron: New York State of Mind

June 1, 2013

Led by two New Yorkers with a mindset that marries novel scientific insights to the processing power of novel technologies, Regeneron's success is a revolutionary challenge to the industry status quo.

The Health Information Advantage

May 1, 2013

For the hard-pressed oncology practice, new technologies hold the key to surviving—and thriving.

Pfizer's Quality by Design Approach to Trial Management

April 1, 2013

Improving the quality of clinical trials is a major strategic activity for Big Pharma, one where efficient management of a demanding set of regulatory requirements can have a positive impact on the bottom line.

Specialty Service Programs: Gearing up for Next Generation Technologies

March 1, 2013

Innovation in hub program design for patient scrip data and clinical support services can lead to increased market share in the hotly contested specialty medicine space.

To Mobile App or Not to Mobile App? That is the IT Question

November 5, 2012

If we swallow the hype and decide that we all need to get onto the mobile app bandwagon, how exactly do we go about it? Sven Awege explains.

Stem Cells: A Promise Deferred?

October 1, 2012

Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures.

Sciformix – Integrated Drug Safety

September 27, 2012

Sciformix's Integrated Drug Safety solution seamlessly interweaves and synchronizes services across all phases of the product lifecycle.

Sciformix white paper

July 31, 2012

Sciformix white paper

Pharma Surges Ahead in Online Communication

July 11, 2012

It may surprise some working in the industry, but pharmaceutical companies, in particular those in Europe, rank among the world’s best online corporate communicators, writes David Bowen.


Click here